Immunome Inc. (IMNM) Appoints Sandra M. Swain to its Board

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/5/2026

1. NVDA
2. PCVX
3. SPY
4. PTC
5. MSFT
6. META
7. AMD
8. GMAB
9. AMZN
10. ATH

Go back to Immunome Inc. (IMNM) Appoints Sandra M. Swain to its Board

Immunome Appoints Sandra M. Swain to Board of Directors

April 25, 2024 8:26 AM EDT

BOTHELL, Wash.--(BUSINESS WIRE)-- Immunome, Inc. (Nasdaq: IMNM), a biotechnology company focused on developing first-in-class and best-in-class targeted cancer therapies, today announced the appointment of Sandra M. Swain, M.D., to its Board of Directors. Dr. Swain has over 30 years of oncology clinical research experience and has served on both public company and non-profit boards.

Immunome is pleased to welcome Sandra to the Board of Directors, especially given her extensive experience as a successful clinical researcher, stated Clay Siegall, PhD, President and Chief Executive Officer of Immunome. Her deep understanding... More